Clinical significance of amylase isoenzyme determination.

J Skrha, J Stĕpán
{"title":"Clinical significance of amylase isoenzyme determination.","authors":"J Skrha,&nbsp;J Stĕpán","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Total amylase activity in serum and urine is formed by pancreatic (P) and salivary (S) isoenzymes. The evaluation of isoamylases provides better information on enzyme changes during the disease than total activities alone. The resolution of pancreatic from extrapancreatic origin of hyperamylasemia may be clinically important. The experience obtained from the analysis of isoamylases in more than 1500 patients with different clinical diagnoses we compare with a contemporary knowledge of disturbances in amylase activities. We developed a method separating quantitatively both isoamylases on the mini-columns of ion-exchanger which we used in routine clinical investigation. In the first section we selected the findings on physiology and biochemistry of isoamylases. We described for the first time a significant decrease of P-isoamylase activity in serum during the intravenous infusions of hypertonic glucose, amino acids and during acute hypercalcaemia. We suggested that hypertonic glucose, amino acids and calcium may regulate directly or indirectly the amylase flux from acinar cells in the pancreas across basolateral membrane into blood. This endocrine secretion of amylase may be important in different clinical conditions in which changes of neurohumoral and/or hormonal regulation are developed. The isoamylase activities in patients with different diagnosis are analyzed in the clinical section. The results may be correctly evaluated only in connection with the pathogenesis of isoamylase changes. Disorders of the organs producing amylase (i.e. pancreas or salivary glands) may induce changes of isoamylases depending on their functional status. A progressive loss of amylase producing cells may be accompanied by a decrease of enzyme activity in serum as was described in chronic pancreatitis with exocrine insufficiency. However, the amylase activity in serum is significantly influenced by clearance mechanisms, too. Disorders of the liver or kidneys are accompanied predominantly with hyperamylasemia caused by the disturbed clearance mechanisms. The amylase activity in serum is a consequence of the result between input and output of the enzyme within the blood stream. Some humoral and hormonal regulations are able to modulate both processes in vivo. We suppose that pathogenetic standpoint has the main role for correct interpretation of isoamylase activities. The pathogenesis of hyperamylasemia is therefore discussed in single chapters. In conclusion, the isoamylase activities in serum and urine are influenced beside genetic background by many factors in health and disease which may be respected during the evaluation of the results.</p>","PeriodicalId":7272,"journal":{"name":"Acta Universitatis Carolinae. Medica. Monographia","volume":"120 ","pages":"1-81"},"PeriodicalIF":0.0000,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Universitatis Carolinae. Medica. Monographia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Total amylase activity in serum and urine is formed by pancreatic (P) and salivary (S) isoenzymes. The evaluation of isoamylases provides better information on enzyme changes during the disease than total activities alone. The resolution of pancreatic from extrapancreatic origin of hyperamylasemia may be clinically important. The experience obtained from the analysis of isoamylases in more than 1500 patients with different clinical diagnoses we compare with a contemporary knowledge of disturbances in amylase activities. We developed a method separating quantitatively both isoamylases on the mini-columns of ion-exchanger which we used in routine clinical investigation. In the first section we selected the findings on physiology and biochemistry of isoamylases. We described for the first time a significant decrease of P-isoamylase activity in serum during the intravenous infusions of hypertonic glucose, amino acids and during acute hypercalcaemia. We suggested that hypertonic glucose, amino acids and calcium may regulate directly or indirectly the amylase flux from acinar cells in the pancreas across basolateral membrane into blood. This endocrine secretion of amylase may be important in different clinical conditions in which changes of neurohumoral and/or hormonal regulation are developed. The isoamylase activities in patients with different diagnosis are analyzed in the clinical section. The results may be correctly evaluated only in connection with the pathogenesis of isoamylase changes. Disorders of the organs producing amylase (i.e. pancreas or salivary glands) may induce changes of isoamylases depending on their functional status. A progressive loss of amylase producing cells may be accompanied by a decrease of enzyme activity in serum as was described in chronic pancreatitis with exocrine insufficiency. However, the amylase activity in serum is significantly influenced by clearance mechanisms, too. Disorders of the liver or kidneys are accompanied predominantly with hyperamylasemia caused by the disturbed clearance mechanisms. The amylase activity in serum is a consequence of the result between input and output of the enzyme within the blood stream. Some humoral and hormonal regulations are able to modulate both processes in vivo. We suppose that pathogenetic standpoint has the main role for correct interpretation of isoamylase activities. The pathogenesis of hyperamylasemia is therefore discussed in single chapters. In conclusion, the isoamylase activities in serum and urine are influenced beside genetic background by many factors in health and disease which may be respected during the evaluation of the results.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
淀粉酶同工酶测定的临床意义。
血清和尿液中的总淀粉酶活性由胰腺(P)和唾液(S)同工酶组成。同淀粉酶的评价提供了更好的信息,在疾病期间的酶的变化比总活性单独。从胰外起源的高淀粉酶血症中分离胰腺可能具有重要的临床意义。从1500多名不同临床诊断的患者的异淀粉酶分析中获得的经验,我们将其与当代淀粉酶活性紊乱的知识进行比较。我们开发了一种在离子交换器微型柱上定量分离两种同淀粉酶的方法,并用于常规临床研究。在第一部分中,我们选择了异淀粉酶的生理生化研究结果。我们首次描述了静脉输注高渗葡萄糖、氨基酸和急性高钙血症期间血清p -异淀粉酶活性的显著下降。我们认为,高渗葡萄糖、氨基酸和钙可能直接或间接地调节胰腺腺泡细胞的淀粉酶通量,使其穿过基底外膜进入血液。这种淀粉酶的内分泌分泌在不同的临床条件下可能是重要的,在这些条件下神经体液和/或激素调节发生了变化。临床分析不同诊断患者的异淀粉酶活性。只有与异淀粉酶改变的发病机制相联系,才能正确地评价结果。产生淀粉酶的器官(即胰腺或唾液腺)的紊乱可引起异淀粉酶的变化,这取决于它们的功能状态。淀粉酶产生细胞的逐渐丧失可能伴随着血清中酶活性的降低,正如慢性胰腺炎伴外分泌功能不全所描述的那样。然而,血清淀粉酶活性也受清除机制的显著影响。肝脏或肾脏疾病主要伴有由紊乱的清除机制引起的高淀粉酶血症。血清中淀粉酶的活性是血液中淀粉酶的输入和输出之间的结果。一些体液和激素调节能够在体内调节这两个过程。我们认为病原学观点在正确解释异淀粉酶活性方面起着主要作用。因此,高淀粉酶血症的发病机制在单独的章节中讨论。综上所述,血清和尿液中的异淀粉酶活性除了受到遗传背景的影响外,还受到许多健康和疾病因素的影响,这些因素在评价结果时应予以考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Neonatal Surgery Parastremmatic dwarfism. Prognosis in childhood epilepsy. The head problem. The organizational significance of segmentation in head development. Paleopathological and paleodemographical analysis of Sarmatian osteological series originating from southern Hungary.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1